AstraZeneca at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
AstraZeneca brings 8 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 624. The drugmaker's posters report real-world use and safety of trastuzumab deruxtecan, ESR1 mutations and liquid biopsy uptake in HR-positive disease, and AI models that read tumor slides.
| Organization | SABCS 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 624 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Fri Dec 11 12:30–2pm |
Find decision makers at AstraZeneca
Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction